Welcome to LookChem.com Sign In|Join Free
  • or
2-(MethylsulfonaMido)phenylacetonitrile is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

36268-70-9

Post Buying Request

36268-70-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

36268-70-9 Usage

Synonyms

MSLI-015

Chemical Class

Nitrile derivative

Parent Compound

2-(methylsulfonamido)phenylacetic acid

Properties

+ Anti-inflammatory
+ Antitumor

Potential Uses

+ Cancer treatment
+ Autoimmune disease treatment
+ Inflammatory condition treatment

Mechanism of Action

+ Inhibition of pro-inflammatory mediators and cytokines production

Significance

+ Potential in the development of new pharmaceuticals

Check Digit Verification of cas no

The CAS Registry Mumber 36268-70-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,6,2,6 and 8 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 36268-70:
(7*3)+(6*6)+(5*2)+(4*6)+(3*8)+(2*7)+(1*0)=129
129 % 10 = 9
So 36268-70-9 is a valid CAS Registry Number.

36268-70-9Downstream Products

36268-70-9Relevant academic research and scientific papers

Novel thiourea derivatives and the pharmaceutical compositions containing the same

-

, (2008/06/13)

The present invention relates to novel thiourca derivatives as a modulator for vanilloid receptor (VR) and the phar- maceutical compositions containing the same. As diseases associated with the activity of vanilloid receptor, pain acute pain, chronic pain, neuropathic pain, post-operative pain, migraine, arthralgia, neuropathies, nerve injury, diabetic neuropathy, neurodegeneration, neurotic skin disorder, stroke, urinary bladder hypersensitiveness, irritable bowel syndrome, a respiratory disorder such as asthma or chronic obstructive pulmonary disease, irritation of skin, eye or mucous membrane, fervescence, stomach-duodenal ulcer, inflam- matory bowel disease and inflammatory diseases can be enumerated. The present invention provides a pharmaceutical composition for prevention or treatment of these diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 36268-70-9